RS34095326 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Apolipoprotein B levels | A | OR: 0.23 | 2E-747 | PubMed |
| C-reactive protein levels | A | OR: 0.19 | 8E-503 | PubMed |
| Low density lipoprotein cholesterol levels | A | OR: 0.19 | 3E-492 | PubMed |
| Total cholesterol levels | A | OR: 0.16 | 6E-365 | PubMed |
| Alzheimer's disease or family history of Alzheimer's disease | A | — | 8E-158 | PubMed |
| Alzheimer's disease | A | — | 2E-85 | PubMed |
| Apolipoprotein A1 levels | A | β: 0.079 | 2E-79 | PubMed |
| Baseline memory | — | OR: 0.21 | 2E-62 | PubMed |
| Baseline memory | — | OR: 0.21 | 3E-61 | PubMed |
| Memory decline | — | β: 0.024 | 9E-59 | PubMed |
| Memory decline | — | β: 0.023 | 5E-57 | PubMed |
| High density lipoprotein cholesterol levels | A | β: 0.057 | 2E-41 | PubMed |
| Memory decline | — | β: 0.021 | 3E-40 | PubMed |
| Memory decline | — | β: 0.021 | 1E-39 | PubMed |
| Baseline memory | — | OR: 0.16 | 1E-32 | PubMed |
| Baseline memory | — | OR: 0.16 | 2E-32 | PubMed |
| Aspartate aminotransferase to alanine aminotransferase ratio | A | β: 0.048 | 2E-32 | PubMed |
| Baseline memory in impaired cognition | — | OR: 0.24 | 3E-26 | PubMed |
| Memory decline in impaired cognition | — | β: 0.028 | 4E-24 | PubMed |
| Alanine aminotransferase levels | A | β: 0.039 | 2E-22 | PubMed |